Edwards Lifesciences Buy or Sell Recommendation

Macroaxis provides Edwards Lifesciences Corporation buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Edwards Lifesciences positions. The advice algorithm takes into account all of Edwards Lifesciences Corporation available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Edwards Lifesciences buy-and-hold prospective. Additionally see Edwards Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Time Horizon

Risk Tolerance

Execute Advice
Edwards Lifesciences Corporation -- USA Stock  

USD 130.21  3.61  2.70%

Allowing for the 30-days total investment horizon, and your above average risk tolerance our recommendation regarding Edwards Lifesciences Corporation is 'Strong Buy'.
For the selected time horizon Edwards Lifesciences Corporation has a risk adjusted performance of 0.3937, jensen alpha of 0.5357, total risk alpha of 0.5977, sortino ratio of 0.2314 and treynor ratio of 0.6325
Macroaxis provides buy, hold, or sell suggestion on Edwards Lifesciences to complement and cross-verify current analyst consensus on Edwards Lifesciences Corporation. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Edwards Lifesciences is not overpriced, please confirm all Edwards Lifesciences fundamentals including its EBITDA, Earnings Per Share, Z Score, as well as the relationship between Debt to Equity and Total Asset . Given that Edwards Lifesciences has Price to Earning of 46.77 times, we urge you verify Edwards Lifesciences Corporation market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return0.45Value At Risk3.89
Potential Upside3.43Standard Deviation1.96
 Return Density 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares21.3 M2.4 B
Blackrock IncCommon Shares15.4 M1.7 B
State Street CorpCommon Shares8.7 M982 M
Bank Of New York Mellon CorpCommon Shares7.6 M854.4 M
Sands Capital Management LlcCommon Shares7 M784 M
Wellington Management Group LlpCommon Shares6.6 M739 M
Alliancebernstein LpCommon Shares6.3 M705.5 M

Edwards Lifesciences Greeks

Alpha over DOW
Beta against DOW=0.70
Overall volatility
Information ratio =0.30

Edwards Lifesciences Volatility Alert

Edwards Lifesciences Corporation currently demonstrates below average downside deviation of 2.5. It has Information Ratio of 0.3 and Jensen Alpha of 0.54. However, we do advice investors to further question Edwards Lifesciences Corporation expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.
 Better Than Average     
 Worse Than Average Compare Edwards Lifesciences to competition
FundamentalsEdwards LifesciencesPeer Average
Return On Equity20.94 % (15.17) %
Return On Asset12.53 % (15.64) %
Profit Margin16.99 % (5.50) %
Operating Margin29.77 % (10.91) %
Current Valuation26.32 B152.14 B
Shares Outstanding211.62 M1.43 B
Shares Owned by Insiders3.94 % 6.91 %
Number of Shares Shorted2.23 M3.24 M
Price to Earning46.77 times40.69 times
Price to Book9.00 times14.44 times
Price to Sales7.78 times17.81 times
Revenue3.44 B9.85 B
Gross Profit2.17 B21.75 B
EBITDA1.1 B1.41 B
Net Income583.6 M517.71 M
Cash and Equivalents1.34 B3.89 B
Cash per Share6.34 times5.17 times
Total Debt1.04 B7.36 B
Debt to Equity35.00 % 0.72 %
Current Ratio1.80 times3.30 times
Book Value Per Share14.02 times13.64 times
Cash Flow from Operations837.9 M1.25 B
Short Ratio1.23 times2.09 times
Earnings Per Share2.70 times2.30 times
Price to Earnings To Growth1.80 times1.22 times
Number of Employees9.8 K10.67 K
Market Capitalization26.72 B29.78 B
Total Asset4.06 B126.86 B
Retained Earnings3.91 B38.24 B
Working Capital1.57 B3.58 B
Current Asset2.05 B36.8 B
Current Liabilities476.2 M33.34 B
Strong Buy


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Sale by Donald Bobo of 2120 shares of Edwards Lifesciences [view details]
Risk Adjusted Performance0.3937
Market Risk Adjusted Performance0.6425
Mean Deviation1.32
Semi Deviation1.72
Downside Deviation2.5
Coefficient Of Variation434.82
Standard Deviation1.96
Information Ratio0.2951
Jensen Alpha0.5357
Total Risk Alpha0.5977
Sortino Ratio0.2314
Treynor Ratio0.6325
Maximum Drawdown8.38
Value At Risk3.89
Potential Upside3.43
Downside Variance6.23
Semi Variance2.95
Expected Short fall1.45

Current Valuation

Edwards Lifesciences Current Valuation Analysis
Edwards Lifesciences Corporation is rated # 5 in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Healthcare Products industry is currently estimated at about 240.38 Billion. Edwards Lifesciences retains roughly 26.32 Billion in current valuation claiming about 11% of equities under Healthcare Products industry.